FEHB Open Season Weight Loss Injection Cover – How To Compare Drug Lists

During FEHB Open Season, many federal employees and retirees find that a plan’s drug list matters as much as its monthly premium. For weight-management medicines, the key questions are whether the prescription appears on the formulary, what tier it sits on, and whether limits such as prior authorization, network pharmacy rules, or deductible requirements apply. A careful side-by-side review can reveal meaningful differences in out-of-pocket cost and access.

FEHB Open Season Weight Loss Injection Cover – How To Compare Drug Lists

Comparing FEHB drug coverage is easier when you treat each plan brochure and drug list as a set of rules, not just a yes-or-no answer. A medicine may appear on a formulary but still require extra approval, a higher tier copay, or use of a preferred pharmacy. During Open Season, the most useful approach is to check the exact drug name, dose, and quantity, then match that information against the plan’s benefits, pharmacy terms, and utilization rules. This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.

What the formulary tells you

A formulary is the plan’s official list of covered prescription drugs, and it is usually the first place to begin. For weight-management medicines, one plan may list a drug as covered, another may exclude it, and a third may cover it only for certain diagnoses or after step therapy. When reviewing the formulary, look beyond the drug name and confirm the strength, injection format, refill limits, and whether the listing notes any restrictions. It is also useful to check when the formulary was last updated, because drug lists can change during the plan year.

Coverage, tier, and benefits

Coverage and tier placement often decide how practical a prescription really is. A drug on a lower tier may involve less cost sharing, while a specialty or non-preferred tier can raise out-of-pocket spending substantially. In FEHB plans, pharmacy benefits may also work differently from medical benefits, so it helps to verify whether the injection is processed through the retail pharmacy benefit, a specialty pharmacy, or occasionally another channel. Reading the benefits section and the formulary together gives a better picture than checking either document alone.

Why copay and deductible matter

Two plans can both cover the same medicine and still produce very different yearly costs. A flat copay may be easier to predict, but some plans apply coinsurance or require you to meet a deductible first. That means the first fills of the year may cost much more than later refills. It is worth checking whether the deductible applies to brand-name prescriptions, whether there is a separate pharmacy deductible, and whether mail-order pricing differs from retail fills. Those details often matter more than the plan premium when comparing ongoing treatment costs.

How pharmacy and network rules affect access

Network design can affect both convenience and price. Some FEHB plans steer members toward preferred pharmacies, home delivery, or specialty pharmacy partners for higher-cost medicines. If your plan’s network is limited, filling the prescription outside that network may result in higher cost sharing or no coverage at all. Access questions also include whether the pharmacy can regularly stock the medication, whether refills can be synchronized, and how shortages are handled. A plan that looks similar on paper may feel very different in practice if its pharmacy network is narrow or its specialty process is more complex.

Cost comparison for common injections

Real-world pricing for these medicines can be high before insurance, which is why the formulary review matters so much. Even when a drug is covered, your actual spending depends on tier status, deductible rules, coinsurance, and the pharmacy you must use. The figures below are broad monthly cash-price estimates or manufacturer list-price approximations commonly cited for the U.S. market, and they should be treated as reference points rather than guaranteed amounts. When comparing FEHB plans, focus on whether the medicine is covered and what cost-sharing method applies after plan rules are triggered.


Product/Service Name Provider Key Features Cost Estimation
Wegovy Novo Nordisk Weekly GLP-1 injection approved for chronic weight management About $1,300 to $1,400 per 28-day supply before insurance
Zepbound Eli Lilly Weekly GIP/GLP-1 injection approved for chronic weight management About $1,050 to $1,100 per month before insurance
Saxenda Novo Nordisk Daily GLP-1 injection approved for chronic weight management Often around $1,300 or more per month before insurance

Prices, rates, or cost estimates mentioned in this article are based on the latest available information but may change over time. Independent research is advised before making financial decisions.

When prior authorization limits apply

Prior authorization is one of the most important details to check because it can delay access even when the drug is listed as covered. Plans may require documentation of diagnosis, body-mass-index criteria, prior treatment history, or evidence that other approaches were tried first. Some plans also set quantity limits or reauthorization rules after the first approval period. Reviewing these prescription rules during Open Season helps you compare not only whether a drug is technically available, but also how much administrative effort may be involved in starting or continuing therapy.

A careful FEHB comparison works best when you read the drug list, benefits booklet, and pharmacy rules together. Formulary status is only the starting point; tier placement, copay structure, deductible exposure, network requirements, and prior authorization can all change the real value of coverage. Looking at those elements side by side gives a clearer, more practical view of how a plan may handle weight-management prescriptions over the course of the year.